{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:41:21Z","timestamp":1790800881151,"version":"4.1.0"},"reference-count":49,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:00:00Z","timestamp":1694822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH\/ORIP","award":["P51OD011104"],"award-info":[{"award-number":["P51OD011104"]}]},{"name":"NIH\/ORIP","award":["R21AI161567-01"],"award-info":[{"award-number":["R21AI161567-01"]}]},{"name":"Tulane National Primate Research Center","award":["P51OD011104"],"award-info":[{"award-number":["P51OD011104"]}]},{"name":"Tulane National Primate Research Center","award":["R21AI161567-01"],"award-info":[{"award-number":["R21AI161567-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The ability of each new SARS-CoV-2 variant to evade host humoral immunity is the focus of intense research. Each variant may also harbor unique replication capabilities relevant for disease and transmission. Here, we demonstrate a new approach to assessing viral replication kinetics using real-time cell analysis (RTCA). Virus-induced cell death is measured in real time as changes in electrical impedance through cell monolayers while images are acquired at defined intervals via an onboard microscope and camera. Using this system, we quantified replication kinetics of five clinically important viral variants: WA1\/2020 (ancestral), Delta, and Omicron subvariants BA.1, BA.4, and BA.5. Multiple measures proved useful in variant replication comparisons, including the elapsed time to, and the slope at, the maximum rate of cell death. Important findings include significantly weaker replication kinetics of BA.1 by all measures, while BA.5 harbored replication kinetics at or near ancestral levels, suggesting evolution to regain replicative capacity, and both an altered profile of cell killing and enhanced fusogenicity of the Delta variant. Together, these data show that RTCA is a robust method to assess replicative capacity of any given SARS-CoV-2 variant rapidly and quantitatively, which may be useful in assessment of newly emerging variants.<\/jats:p>","DOI":"10.3390\/v15091937","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T06:36:45Z","timestamp":1694932605000},"page":"1937","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Real-Time Analysis of SARS-CoV-2-Induced Cytolysis Reveals Distinct Variant-Specific Replication Profiles"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9899-997X","authenticated-orcid":false,"given":"Sarah E.","family":"Scheuermann","sequence":"first","affiliation":[{"name":"Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70433, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Goff","sequence":"additional","affiliation":[{"name":"Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70433, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3744-496X","authenticated-orcid":false,"given":"Lori A.","family":"Rowe","sequence":"additional","affiliation":[{"name":"Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70433, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9438-1304","authenticated-orcid":false,"given":"Brandon J.","family":"Beddingfield","sequence":"additional","affiliation":[{"name":"Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70433, USA"},{"name":"Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9332-7891","authenticated-orcid":false,"given":"Nicholas J.","family":"Maness","sequence":"additional","affiliation":[{"name":"Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70433, USA"},{"name":"Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First Case of 2019 Novel Coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.cell.2020.06.040","article-title":"Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear","volume":"182","author":"Grubaugh","year":"2020","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cell.2020.11.020","article-title":"Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity","volume":"184","author":"Volz","year":"2021","journal-title":"Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e1120","DOI":"10.1093\/cid\/ciab754","article-title":"Severity of SARS-CoV-2 alpha variant (B.1.1.7) in England","volume":"75","author":"Grint","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"109292","DOI":"10.1016\/j.celrep.2021.109292","article-title":"Recurrent emergence of SARS-CoV-2 spike deletion H69\/V70 and its role in the Alpha variant B.1.1.7","volume":"35","author":"Meng","year":"2021","journal-title":"Cell Rep."},{"key":"ref_6","unstructured":"(2023, August 31). Investigation of Novel SARS-CoV-2 Variant: Variant of Concern 202012\/01, Technical Briefing 3, Available online: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/959360\/Variant_of_Concern_VOC_202012_01_Technical_Briefing_3.pdf."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41586-021-03402-9","article-title":"Detection of a SARS-CoV-2 variant of concern in South Africa","volume":"592","author":"Tegally","year":"2021","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1126\/science.abh2644","article-title":"Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil","volume":"372","author":"Faria","year":"2021","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"veab091","DOI":"10.1093\/ve\/veab091","article-title":"Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern","volume":"7","author":"Graf","year":"2021","journal-title":"Virus Evol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-022-05200-3","article-title":"Context-specific emergence and growth of the SARS-CoV-2 Delta variant","volume":"610","author":"McCrone","year":"2022","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41586-021-04069-y","article-title":"Genomic reconstruction of the SARS-CoV-2 epidemic in England","volume":"600","author":"Vohringer","year":"2021","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"100929","DOI":"10.1016\/j.nmni.2021.100929","article-title":"Genetic emergence of B.1.617.2 in COVID-19","volume":"43","author":"Kirola","year":"2021","journal-title":"New Microbes New Infect."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"110218","DOI":"10.1016\/j.celrep.2021.110218","article-title":"The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance","volume":"38","author":"Kimura","year":"2022","journal-title":"Cell Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"eabm4908","DOI":"10.1126\/scitranslmed.abm4908","article-title":"Characterization of the SARS-CoV-2 B.1.621 (Mu) variant","volume":"14","author":"Halfmann","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e2381","DOI":"10.1002\/rmv.2381","article-title":"Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission","volume":"32","author":"Shrestha","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e0009022","DOI":"10.1128\/jvi.00090-22","article-title":"SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant","volume":"96","author":"Berkhout","year":"2022","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/d41586-023-00014-3","article-title":"Coronavirus variant XBB.1.5 rises in the United States\u2014Is it a global threat?","volume":"613","author":"Callaway","year":"2023","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1473-3099(22)00805-2","article-title":"Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection","volume":"23","author":"Jiang","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_20","unstructured":"Chen, J., Wang, R., and Wei, G.W. (2021). Review of the mechanisms of SARS-CoV-2 evolution and transmission. arXiv."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Wiegand, T., Nemudryi, A., Nemudraia, A., McVey, A., Little, A., Taylor, D.N., Walk, S.T., and Wiedenheft, B. (2022). The Rise and Fall of SARS-CoV-2 Variants and Ongoing Diversification of Omicron. Viruses, 14.","DOI":"10.1101\/2022.02.09.479842"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41591-021-01294-w","article-title":"Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies","volume":"27","author":"Chen","year":"2021","journal-title":"Nat. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.chom.2021.02.003","article-title":"Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies","volume":"29","author":"Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cell.2022.12.018","article-title":"Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","article-title":"SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma","volume":"27","author":"Wibmer","year":"2021","journal-title":"Nat. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1056\/NEJMoa2105000","article-title":"Vaccine Breakthrough Infections with SARS-CoV-2 Variants","volume":"384","author":"Hacisuleyman","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41586-021-04085-y","article-title":"Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity","volume":"600","author":"Lucas","year":"2021","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/22221751.2021.2022440","article-title":"Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost","volume":"11","author":"Ai","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2101196","DOI":"10.2807\/1560-7917.ES.2022.27.4.2101196","article-title":"Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022","volume":"27","author":"Eggink","year":"2022","journal-title":"Eurosurveillance"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41591-022-02162-x","article-title":"Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster","volume":"29","author":"Kurhade","year":"2023","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","volume":"596","author":"Planas","year":"2021","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.chom.2021.06.006","article-title":"SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity","volume":"29","author":"Motozono","year":"2021","journal-title":"Cell Host Microbe"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Escalera, A., Gonzalez-Reiche, A.S., Aslam, S., Mena, I., Pearl, R.L., Laporte, M., Fossati, A., Rathnasinghe, R., Alshammary, H., and van de Guchte, A. (2021). SARS-CoV-2 variants of concern have acquired mutations associated with an increased spike cleavage. bioRxiv, 2021.2008.2005.455290.","DOI":"10.1101\/2021.08.05.455290"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41422-022-00619-9","article-title":"Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates","volume":"32","author":"Bojkova","year":"2022","journal-title":"Cell Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"20230187","DOI":"10.1098\/rsif.2023.0187","article-title":"Modelling the viral dynamics of the SARS-CoV-2 Delta and Omicron variants in different cell types","volume":"20","author":"McCormack","year":"2023","journal-title":"J. R. Soc. Interface"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","article-title":"SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo","volume":"603","author":"Hui","year":"2022","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41564-022-01143-7","article-title":"SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway","volume":"7","author":"Willett","year":"2022","journal-title":"Nat. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"105517","DOI":"10.1016\/j.jcv.2023.105517","article-title":"In vitro fitness of SARS-CoV-2 variants as assessed by competition experiments followed by ddRT-PCR and whole genome sequencing","volume":"165","author":"Carbonneau","year":"2023","journal-title":"J. Clin. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity","volume":"603","author":"Meng","year":"2022","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"100013","DOI":"10.1016\/j.crviro.2021.100013","article-title":"Review Devil's tools: SARS-CoV-2 antagonists against innate immunity","volume":"2","author":"Xu","year":"2021","journal-title":"Curr. Res. Virol. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fcimb.2018.00335","article-title":"Development of a Real-Time Cell Analysis (RTCA) Method as a Fast and Accurate Method for Detecting Infectious Particles of the Adapted Strain of Hepatitis A Virus","volume":"8","author":"Lebourgeois","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/bs.mie.2019.07.020","article-title":"Real-time cell analysis (RTCA) to measure killer cell activity against adherent tumor cells in vitro","volume":"631","author":"Oberg","year":"2020","journal-title":"Methods Enzymol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jviromet.2017.11.002","article-title":"Robust real-time cell analysis method for determining viral infectious titers during development of a viral vaccine production process","volume":"252","author":"Charretier","year":"2018","journal-title":"J. Virol. Methods"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Rowe, L.A., Beddingfield, B.J., Goff, K., Killeen, S.Z., Chirichella, N.R., Melton, A., Roy, C.J., and Maness, N.J. (2022). Intra-Host SARS-CoV-2 Evolution in the Gut of Mucosally-Infected Chlorocebus aethiops (African Green Monkeys). Viruses, 14.","DOI":"10.3390\/v14010077"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1002\/cpmc.108","article-title":"An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening","volume":"58","author":"Amanat","year":"2020","journal-title":"Curr. Protoc. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"104629","DOI":"10.1016\/j.idnow.2022.10.001","article-title":"Prolonged replication of BA.1 and BA.2 Omicron lineages compared to Delta variant in nasopharyngeal samples from COVID-19 patients","volume":"53","author":"Teyssou","year":"2023","journal-title":"Infect. Dis. Now"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41586-021-04266-9","article-title":"Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation","volume":"602","author":"Saito","year":"2022","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"103934","DOI":"10.1016\/j.ebiom.2022.103934","article-title":"Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2","volume":"77","author":"Saunders","year":"2022","journal-title":"EBioMedicine"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/9\/1937\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:52:10Z","timestamp":1760129530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/9\/1937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,16]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["v15091937"],"URL":"https:\/\/doi.org\/10.3390\/v15091937","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,16]]}}}